Inflammation, obesity and comorbidities: the role of diet
- 1 October 2007
- journal article
- review article
- Published by Cambridge University Press (CUP) in Public Health Nutrition
- Vol. 10 (10A), 1164-1172
- https://doi.org/10.1017/s1368980007000663
Abstract
The adipocyte metabolism has been shown to change during the fat enlargement process associated to obesity. Several procoagulant proteins such as plasminogen activator inhibitor type 1, tissue factor or factor VII and also inducible nitric oxide synthase show higher expression in adipose tissue of obese people in comparison to lean. This overexpression could explain at least a part of the atherogenic and cardiovascular risk associated with obesity. In addition to cytokine secretion, many other features have been observed to be common to adipocyte and monocyte/macrophage lines: for example, phagocytic and microbicidal activities, and possibly a cellular plasticity of adipose precursors. Overweight and obesity are associated with an increased risk of such metabolic abnormalities as dyslipidemia, hypertension or type 2 diabetes mellitus and cardiovascular diseases, common features of the metabolic syndrome. Initially, insulin resistance or hyperinsulinemia was suggested as the origin of these abnormalities. More recent studies indicate that adipokynes have an important role in obesity-associated metabolic complications, and suggest that chronically elevated local or systemic concentrations of adipokynes contribute to the development of complications associated with obesity and metabolic syndrome. Considering all the evidence relating to diet and inflammation, the best diet for protecting against the metabolic derangements associated with obesity and metabolic syndrome would be high in fibre-rich cereals, fruit, vegetables, fish, virgin olive oil and nuts; moderate in wine; and low in meat, processed meat foods and trans-fatty acids.Keywords
This publication has 101 references indexed in Scilit:
- Visfatin in adipocytes is upregulated by hypoxia through HIF1α-dependent mechanismBiochemical and Biophysical Research Communications, 2006
- Subcutaneous adipose tissue cytokine production is not responsible for the restoration of systemic inflammation markers during weight lossInternational Journal of Obesity, 2006
- Anti-inflammatory effects of polyunsaturated fatty acids in THP-1 cellsBiochemical and Biophysical Research Communications, 2005
- Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissuesBlood, 2004
- Serum carotenoids and vitamins in relation to markers of endothelialEuropean Journal of Epidemiology, 2004
- Effect of a Mediterranean-Style Diet on Endothelial Dysfunction and Markers of Vascular Inflammation in the Metabolic SyndromeJAMA, 2004
- High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefitAmerican Heart Journal, 2004
- Clinical use of high sensitivity C-reactive protein for the prediction of adverse cardiovascular eventsCurrent Opinion in Cardiology, 2003
- Acute-Phase Proteins and Other Systemic Responses to InflammationNew England Journal of Medicine, 1999
- Endothelium-Dependent Vasorelaxation Caused by Various Plant ExtractsJournal of Cardiovascular Pharmacology, 1995